Временное руководство23 декабря 2020 г.
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...s the protocol provided here, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated and analyzed across many different settings globally for timely estimates of 2019-nCoV infection severity and transmissibility, as well as to inform public health responses and policy decisions. This is particularly important in the context of a novel respiratory pathogen, such as 2019-nCoV
more
Zugewanderten Menschen mit Behinderung, die nicht ausreichend Deutsch sprechen, bleibt ohne Sprachmittlung dervolle Zugang zu grundlegenden Rechten versperrt. Besonders deutlich wird dies im Bereich medizinischer Leistungen. Daher ist es not-wendig, einen umfassenden Anspruch auf die F...inanzierung qualitativer Dolmet-schleistungen gesetzlich festzuschreiben.
more
A elaboração das Diretrizes para Diagnóstico e Tratamento da COVID-19 é uma resposta rápida ao enfrentamento da COVID-19, diante da declaração de pandemia pela Organização Mundial de Saúde (OMS) e das iniciativas do Ministério da Saúde para enfrentamento dessa nova situação no Brasil. ...
A intensa produção de evidência sobre o assunto nos últimos meses faz destas Diretrizes um documento dinâmico que terá versões provisórias e atualizações periódicas, acompanhando a produção de novas evidências para assim estabelecer recomendações.
more
Accessed February 6, 2020
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
more
Временные рекомендации23апреля 2020г.
Interim Framework for the South-East Asia Region 28 October 2020
COVID-19, General Epidemiological Surveillance Guidelines (Version 6)